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Abstract
This study expands recent research that examines how the 
receipt of BRCA1 genetic test results affects family adapt­
ability and cohesion 1  year after genetic risk notification. 
Study participants were members of a large Utah-based 
kindred with an identified mutation at the BRCA1 locus. The 
final sample, 90 men and 132 women, contributed informa­
tion before genetic testing (baseline) and 4 months and/or 
1 year after receipt of genetic test results. After controlling 
for other factors such as family coping resources (Family 
Crises-Oriented Personal Evaluation Scale) and strains 
(Family Strains Index) and the tested individual's anxiety 
levels before genetic testing (state anxiety subscale), men 
and women reported significant declines in family cohesion 
1 year after genetic risk notification (P < 0.01). There is 
suggestive evidence that carrier men reported increasing
Introduction
The strong likelihood that carriers of a BRCA1 gene mutation 
will develop breast and ovarian cancer has led a number of 
researchers to examine the potential psychological and 
behavioral effects of genetic testing for BRCA1 mutations for 
individuals (1-6). Mutations in BRCA1 are observed in ~ 50% 
of families with autosomal dominant breast cancer predispo­
sition and in 80% of families with both breast and ovarian 
cancer (7). Female BRCA1 carriers are at increased risk for 
breast and ovarian cancers (8) and male carriers have an 
increased risk of prostate cancer (9). Data from the Breast 
Cancer Linkage Consortium indicate that by the age of 70 
years, female BRCA1 mutation carriers have an 85% risk for 
developing breast cancer and a 63% risk for developing 
ovarian cancer. The cumulative risk of either cancer by this 
age is ~ 94% for female mutation carriers.
The implications of genetic risk notification for families, 
however, have not been explored as thoroughly. According to 
Halbert (10), BRCA1/2 carriers reported greater uncertainty 
about familial implications and greater stress surrounding the 
management of familial concerns 1 month after risk notifica­
tion compared with noncarriers. Mclnerney-Leo et al. (11) 
reported significant declines in family cohesion and expression 
levels among tested high-risk men and women 6 to 9 months 
after genetic risk notification, compared with those who did 
not undergo genetic testing. However, they did not find
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adaptability 1  year after risk notification (+0.21 points per 
month; P  < 0.10). Having a carrier sister had a positive 
influence on women's perceived family cohesion and adap­
tability levels, whereas a personal history of cancer, having 
a great deal of caregiving involvement for a female relative 
with cancer, anxiety, and some types of coping resources had 
a negative effect on men's perceived family cohesion and 
adaptability levels. Although results showed that tested 
parents are perceiving a decline in family functioning after 
genetic risk notification, there is no evidence to suggest that 
the decline is due to carrier status. In fact, it is other life 
circumstances that exist at the time of the genetic testing 
process that seem to influence the degree to which families 
adjust to the experience and test results. (Cancer Epidemiol 
Biomarkers Prev 2007;16(1):135-41)
differences in family cohesion and expressive levels between 
carriers and noncarriers.
This study expands on the recent but limited research 
examining how the receipt of genetic test results affects family 
functioning. The approach adopted here relies on psychosocial 
and coping theory to examine familial effects of BRCA1 testing 
up to 1 year after genetic risk notification while also accounting 
for potential gender differences, the family's coping resources 
and strains, and the tested individual's anxiety level before 
genetic testing. Hierarchical linear modeling techniques are 
used to examine family functioning over time.
The psychosocial stress perspective (12) and the Resiliency 
Model of Family Stress, Adjustment, and Adaptation (hereafter 
called the Resiliency Model; refs. 13, 14) are used to model 
changes in family adaptability and cohesion due to notification 
of BRCA1 mutation status (Fig. 1). Like individuals, families 
develop and operate with specific patterns of interaction, 
resources, and coping strategies to function as a social unit. 
The Resiliency Model emphasizes family coping and social 
resources in the stress process. The model also recognizes that 
existing family typology (hereafter referred to as family func­
tioning) and existing family strains (pile-up) moderate the effect 
of stressful life events, leading to family crisis, maladjustment, 
or adaptation (13,14). In this study, an individual's genetic test 
result (A factor) may disrupt or fortify a family's functioning 
(X factor) with the end result determined in part by existing 
family functioning patterns (T factor) and family strains 
(a factor) and coping strategies (B factor). The approach depicted 
in Fig. 1 represents a merging of stress and family functioning 
models appropriate for addressing three key research questions:
(a) Does BRCA1 carrier status affect perceptions of family 
adaptability and cohesion up to 1 year after genetic testing?
(b) To what extent do family coping strategies and resources 
influence cohesion and adaptability levels after the receipt of 
BRCA1 mutation test results?
(c) Do other life circumstances such as existing family 
strains, familial and individual history of breast cancer, and
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Figure 1. Genetic testing, family 
stress, and family functioning mod­
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the carrier status of other family members moderate the 
effects of genetic test results on family cohesion and 
adaptability levels?
M ateria ls  and M ethods
Data were collected as part of a longitudinal study on the 
psychosocial and behavioral consequences of BRCA1 mutation 
testing. Study participants were members of a large kindred of 
Northern European descent (K2082) with an identified 
mutation at the BRCA1 locus (15). All subjects in the study 
are descendants of a founding couple (four to five generations 
earlier) known to be BRCA1 mutation carriers. The full sample 
consists of 111 geographically distinct households (nuclear 
families) spread throughout Utah and Idaho, with an average 
of 3.3 children. Information for this study was gathered before 
genetic testing (baseline) and 4 months and 1 year after receipt 
of BRCA1 genetic test results. All baseline interviews (that 
preceded genetic counseling) were conducted from September 
1994 to March 1997, following a rolling recruitment strategy 
wherein participants were undergoing genetic counseling and 
testing shortly after consenting to participate. One-year (after 
receipt of test results) follow-up surveys were completed by 
July 1999. A detailed description of recruitment methods, 
eligibility criteria, and protocol for the longitudinal study are 
available elsewhere (16).
Individuals who were <18 years of age, not competent to 
provide informed consent, and untested members who were 
not at risk because they knew that their parents or grand­
parents tested negative for a BRCA1 mutation (16) were 
excluded. The protocol included strict guidelines wherein 
parents are interviewed and offered genetic testing before their 
adult children. All survey data save genetic test results were 
stored at a centralized facility, and interviews were conducted 
via telephone. Informed written consent was obtained from 
each eligible member before enrollment, and genetic counsel­
ing was offered to all interested family members before and 
after genetic testing.
Of the 759 eligible members, 408 (53.75%) completed the 
baseline interview. The sample in this study was further 
restricted to members who completed the baseline and at least 
one of the two follow-up interviews (4 months and/or 1 year) 
and have living children (N  = 259 parents).
Measures
Family Functioning. Family cohesion and adaptability levels 
were measured before (baseline) and 4 months and 1 year after
genetic testing using the Family Adaptability and Cohesion 
Evaluation Scales (FACES II). The FACES II scale has been 
shown to be a highly reliable and valid measure of family 
functioning (17, 18). Cohesion is defined as the emotional 
bonding that family members have toward one another. 
Adaptability is defined as the ability of the family to change 
in power structure, roles, and relationships to adjust to various 
situational stressors.
BRCA1 M utation Status. BRCA1 mutation carrier status was 
determined after the baseline interview but before the 4-month 
follow-up, and defined as positive/carrier, negative/noncar­
rier, and carrier status unknown.
Coping Resources. Family coping data was collected at 
baseline using the Family Crises-Oriented Personal Evalua­
tion Scale (F-COPES; ref. 14), which measures how a family 
uses available familial and social resources in response to life 
events, including acquiring support from extended family 
members, mobilizing family members in a crisis, passive 
appraisal (accepting problematic issues), reframing (redefining 
stressful events to make them more manageable), and seeking 
spiritual support.
Family Strains. Existing family strains were measured at 
baseline by a number of factors, including the Family Strains 
Index (F-STRAIN; ref. 14). F-STRAIN captures stress from 
family, work, financial, and caregiving responsibilities "which 
can render a family vulnerable to the effect of a subsequent 
stressor or change" (13). Other factors, including the partic­
ipant's history of cancer or cancer-related surgery, level 
of caregiving involvement for a female, maternal relative 
with cancer, age, gender, marital status, general anxiety level, 
and suspicions of cancer risk, may also capture the pile-up 
of demands and strains in the family not measured by 
F-STRAIN.
Level of caregiving involvement is considered because it has 
the potential to change family dynamics. Caregiving may also 
influence how the tested parent perceives his or her family 
functioning, and, if a relative with a history of cancer is female 
and related through the maternal branch of the kindred, the 
family's sensitivity toward cancer risk may be heightened. 
Level of caregiving involvement was assessed at baseline with 
two questions, whether the participant had a female, maternal 
relative with a history of cancer and if he/she was involved in 
care of that relative. Those with an affected relative and (a) had 
no caregiving involvement, (b) had some caregiving involve­
ment, and (c) had a great deal of caregiving involvement were 
compared with those with no affected relatives.
Cancer Epidem iol Biomarkers Prev 2007;16(1). January 2007
Cancer Epidemiology, Biomarkers & Prevention 137
General anxiety level (or state anxiety) was measured at 
baseline using the state anxiety subscale (SAS) of Spielberger's 
State-Trait Anxiety Inventory (19). It is considered here to 
control for initial levels of anxiety (at the individual level) 
before obtaining genetic test results.
Prior suspicions of cancer risk were measured at baseline by 
a single question where participants were asked if they knew 
or suspected that they came from a family with members that 
have an elevated risk for developing breast and ovarian cancer. 
If they said they knew or suspected, they were considered 
"suspicious."
Other Variables. Other baseline variables included in the 
analyses were the presence of children in the home, the gender 
composition of the participant's children, household income, 
and the highest education level by either parent (household 
education). Receipt of genetic counseling was measured at the 
4-month follow-up and is an indicator for whether the 
participant received genetic counseling after being tested. 
Because the follow-up counseling session was not mandatory, 
not all participants opted to receive their test results from a 
genetic counselor.
Statistical Analysis. \ 2 analyses and t tests by sex were 
used to evaluate gender differences in mutation status, family 
functioning, and other key demographic variables as BRCA1 
mutations confer varying risks of cancer by sex. We then used 
hierarchical linear modeling to assess changes in family 
functioning while simultaneously accounting for family 
functioning levels before genetic testing, the correlation of 
measures for each participant over time (repeated observa­
tions), and unequal variances (heteroskedasticity) in the 
outcome variable between individuals (20). Another advantage 
of using hierarchical linear modeling is that we were able to 
include more cases in the final analysis as participants who 
completed the baseline and at least one of the two follow-up 
interviews (4 months and/or 1 year) were eligible for inclusion 
in this study.
Hierarchical linear modeling has two phases of estimation. 
Phase 1 is often referred to as the level 1 or repeated measures 
phase, which uses simple regression techniques to estimate 
patterns of change over time for each individual given his or 
her initial family functioning scores (measured at baseline) and 
rates of change as a function of time. The dependent variables 
are perceived adaptability and cohesion, measured separately, 
and the independent variable is time (0-12 months) since the 
baseline interview. These regressions generate an intercept 
(ir0i) and slope ( irl i ) statistic, representing each individual's 
baseline family functioning and growth trajectory up to the
1-year interview, respectively. These estimates are then used in 
the second phase of the analysis, the level 2 or person-level 
phase. Phase 2 estimates average baseline family functioning 
levels among all study participants (jScw) and the differences in 
baseline family functioning levels (jS01) according to family/ 
individual characteristics as well as the residual variation in 
baseline family functioning levels (roi) after controlling for 
other factors. The growth trajectory of family functioning after 
genetic risk notification is estimated using the same technique, 
which estimates the relative effect of family/individual 
characteristics on the average growth trajectory of family 
functioning the differences in the growth trajectory (jSn), 
and the residual variation in growth patterns (rli).
The sample comprises sets of siblings, but approximately 
half of the female sample (60 of 132) and of the male sample 
(46 of 90) have only one sibling represented from their nuclear 
family. Nonetheless, to account for the possibility of correlated 
responses arising from having multiple siblings in the sample, 
we reestimated the models that make adjustments for this 
correlation using generalized estimating equations (21). Results 
from these models do not differ appreciably from those that
make no such adjustment. Accordingly, models reported here 
are not based on adjustments for familial clustering but they do 
adjust for correlated responses due to the fact that we rely on 
repeated responses from the same subject.
In this study, we estimated changes in family adaptability 
and cohesion separately and stratified the analyses by sex. We 
first conducted a preliminary hierarchical linear modeling 
analyses using an unconditional model (i.e., level 2 or person- 
level predictor variables excluded from the model) to assess 
the extent of variability in family functioning scores at baseline 
(j?oo) and changes by the 1-year interview We then
estimated the influence of person/familial characteristics on 
family functioning scores in the final, multivariate model, 
which included all predictor variables.
Results
Of the 259 (63% of 408) individuals who were eligible for 
the study, 206 (80%) completed and returned the 4-month, 
mailed, self-report FACES 11 survey. Fifty-three (20%) failed 
to return the survey or skipped the 4-month interview 
entirely. Another 12 participants were deleted from the 
4-month pool of participants because they were missing five 
or more items on the FACES 11 survey. Overall, there were 
194 (75% of the 259) usable FACES 11 surveys at 4 months. 
At the 1-year interview, 245 (95% of 259) participants were 
eligible for the final analysis. In the end, a total of 222 (90 men 
and 132 women) participant surveys were used in the final 
analysis.
Individual and familial characteristics for men and women 
are described in Table 1. Although the men and women in our 
sample had high rates of genetic counseling attendance, men 
were more likely to attend at least one genetic counseling 
session after being tested compared with women (86.7% and 
77.3%, respectively). Women were more likely to have had a 
history of cancer or cancer-related surgery (31.8% versus
11.1%) and previous exposure to a great deal of caregiving 
involvement (30.3% versus 14.4%). Women were also more 
likely to report higher amounts of family coping, and, although 
suggestive (P < 0.10), women also report higher family strain 
and general anxiety than men.
Men and women reported average levels of cohesion at 
baseline compared with a normed national population with a 
mean of 64.9 (SD, 8.4; refs. 17, 18). However, they reported 
slightly higher levels of adaptability at baseline (normed 
population mean, 49.9; SD, 6.6). Family coping among this 
sample, while slightly lower compared with a normed 
population, falls within 1 SD of mean values, which are 93.12 
(SD, 14.05) for men and 95.64 (SD, 13.24) for women. Family 
strain (F-STRAIN) scores in this sample were within normal 
limits, 4.0 to 11.0 (13). Population norms for general anxiety 
levels (SAS) are not available because general anxiety is 
dependent on the individual and the situation evoking the 
anxious response. However, when compared with hospitalized 
cancer patients, this sample reports lower anxiety levels (22). 
The psychometric properties of SAS, F-STRA1N, F-COPES, and 
FACES 11 were assessed with Chronbach's a statistic and found 
to have good (0.69) to excellent (0.92) internal consistency 
(Table 1).
According to Table 2, there were significant amounts of 
variability in initial family functioning levels reported by both 
men and women (r0i) in this study, although the amount of 
residual variance dramatically declined compared with the 
unconditional model (results not shown). Men and women 
reported significant declines in family cohesion (/J10; P < 0.01), 
and no significant changes in family adaptability were found. 
Table 2 also shows that women reported a steeper decline in 
family cohesion levels compared with men (/J10; —0.23 versus 
—0.19); unlike the men in this study, women reported greater
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Don't know carrier status 7.8 5.3
Cancer/cancer-related surgery 11.1* 31.8*
No children living in the home 26.7 19.7
Marital status
Stayed married by 1 y 100.0 93.2
Stayed single by 1 y 0.0 4.5
Married at baseline/single by 1 y 0.0 2.3
Has at least one living daughter 100.0 89.4
Suspect higher risk for cancer 60.0 64.4
Caregiving involvement
No caregiving involvement 17.8 14.4
Some caregiving involvement 24.4 21.2
A great deal of caregiving involvement 14.4* 30.3*
No female, maternal 43.3 34.1
relative with history of cancer 
Carrier status of relatives
Parent carrier at baseline 12.2 6.8
Parent carrier at 4 mo 18.9 18.2
Sister carrier at baseline 6.7 3.0
Sister carrier at 4 mo 32.2 20.5
Received genetic counseling 86.7 77.3
Median household income ($1,000) 42.5 42.5
Mean household education (y) 15.06 15.08
Mean age at baseline (y) 44.86 43.21
Mean SAS * 29.88'* 31.77'*
Mean F-STRAIN1 6.43'* 8.04'*
Mean F-COPES1 86.4* 93.7*
Family functioning outcomes**
Mean FACES II at baseline 61.32 61.97
Mean cohesion at baseline 65.79 66.78
Mean adaptability at baseline 56.84 57.17
NOTE: Frequency percentages reported, unless otherwise noted. P values refer 
to x" analyses with Fisher's exact tests (right tailed) between men and women. 
*P < 0.01.'
t P <0.05.
t SAS: Chronbach's i  for internal consistency calculated at 0.92.
W < 0.10.
ilF-STRAIN: Chronbach's % for internal consistency calculated at 0.69. 
*iF-COPES: Chronbach's i  for internal consistency calculated at 0.82, subscales
range 0.32-0.83.
**FACES: Chronbach's % for internal consistency calculated at 0.88, 0.89, 0.87 at 
baseline, 4 mo, and 1 yr respectively. Males ranged from 0.87-0.90 and females 
ranged from 0.87-0.89 for all three time periods.
variability in the amount of decline in cohesion levels after 
genetic testing (r^; P < 0.05).
Although the men and women in our study did not know 
their BRCA1 mutation carrier status at baseline, we included it 
in our baseline model to ascertain initial differences, if any, in
family cohesion and adaptability between (as yet unknown) 
carrier and noncarrier families. Table 3 shows that there are no 
differences in cohesion and adaptability levels between carrier, 
noncarrier, and unknown carrier status families before genetic 
risk notification. However, being a male BRCA1 mutation 
carrier is associated with a positive influence on family 
adaptability, increasing adaptability by +0.21 points per month 
more than noncarrier families (P < 0.10).
General anxiety levels (SAS) and family strains (F-STRAIN) 
had significant negative effects on cohesion and adaptability 
levels before genetic testing for both men and women, ranging 
from —0.14 to —0.31. Family coping levels (F-COPES) also had 
expected effects, as men and women report greater cohesion 
and adaptability levels at baseline with increasing social and 
coping resources (ranging from +0.15 to +0.21).
The influences of individual anxiety and family coping on 
cohesion and adaptability patterns after genetic risk notifica­
tion, however, are only evident among the men in our study. 
According to Table 3, men's anxiety level (SAS) before genetic 
testing had a significant negative effect on family cohesion 
levels 1 year after genetic testing. Increasing levels of family 
coping resources (F-COPES) before genetic testing also had a 
negative effect on both cohesion and adaptability for the men, 
dropping —0.01 points per month for every unit increase in 
F-COPES. To explore this unexpected finding, we repeated the 
analyses replacing the composite F-COPES score with specific 
coping subscales (i.e., acquiring support from extended family 
members, mobilizing family members in a crisis, passive 
appraisal, reframing, and seeking spiritual support). We found 
that among men, cohesion levels seemed to be most sensitive 
to coping strategies that included reframing, whereas adapt­
ability levels seemed to be affected by coping strategies that 
included seeking spiritual support. All other types of coping 
mechanisms measured within F-COPES were not associated 
with changes in male cohesion or adaptability (results not 
shown).
Changes in family functioning differed by gender with respect 
to personal cancer history. Although based only on a small 
number of men, our results suggest that men (but not women) 
with a history of cancer experienced a decline in cohesion and 
adaptability, —0.27 and —0.34 points per month, respectively.
The carrier status of sisters and/or parents also affected men 
and women differently. Whereas men were not affected, 
women with a carrier sister reported significant increases in 
both family cohesion and adaptability levels, +0.20 and +0.24 
points per month, respectively.
Table 4 shows that women who had a great deal of 
caregiving involvement for a relative with cancer perceive 
higher adaptability levels before genetic testing compared with 
women who did not have an affected relative (+3.09). The 
results are similar for men, although men reported higher
Table 2. Multivariate-multilevel estimation of initial (baseline) family cohesion and adaptability and subsequent changes 
(slope) 1 yr after BRCA1 genetic risk notification by sex
Final estimation of fixed and random effects Cohesion, coefficient (SE) Adaptability, coefficient (SE)
Men Women Men Women
Baseline intercept Poo 
Slope, /j io
Residual variance: intercept, ro. 
Residual variance: month slope, Th 
Random error, level 1, e t i
65.43* (0.46) 
-0.19* (0.05) 
9.51* (71 df) 




12.70* (110 df) 




13.60* (71 df) 




18.93* (110 df) 
0.04T (110 df) 
17.53
NOTE: Final estimation controls for carrier status, age, children in the home, household education, household income, marital status, suspicions of risk, genetic 
counseling, cancer history, having a daughter, carrier status of parent and /o r sister, caregiving of maternal relative with cancer, anxiety level (SAS), family strain 
(F-STRAIN), family coping levels (F-COPES), and carrier status-suspicions of risk interaction. fi00, mean FACES II score before genetic testing (baseline). /i]0, mean rate 
of change in FACES II scores per month among tested parents. r0i, residual random effect in mean FACES II scores before genetic testing (baseline). r Vu residual 
random effect in mean rates of change in FACES II scores among tested parents. eti, random error for person i  at time t .
*P < 0.01. 
tP  < 0.05.
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Table 3. Significant factors associated w ith initial (baseline) family cohesion and adaptability and subsequent changes 
(slope) 1 yr after BRCA1 genetic risk notification: men
Final estimation of fixed effects Cohesion Adaptability
Intercept coefficient (SE) Slope coefficient (SE) Intercept coefficient (SE) Slope coefficient (SE)
Carrier -2.13 (1.50) 0.16 (0.13) -2.64 (1.64) 0.21* (0.13)
Don't know carrier status -2.81 (2.83) 0.02 (0.28) -4.26 (3.10) -0.05 (0.27)
Age 18-40 y 2.06* (1.44) - 0.10 (0.11) 1.72 (1.25) -0.16 (0.11)
No children living in home -0.37 (1.17) -0.03 (0.11) 0.45 (1.28) -0.07 (0.11)
Household education 0.41 (0.29) -0.02 (0.03) 0.32 (0.32) -0.02 (0.03)
Household income - 0.02 (0.02) - 0.00 (0.00) -0.03 (0.02) - 0.00 (0.00)
Married to single — — — —
Stayed single _ _ _ _ — _ _
Suspect higher risk -0.14 (1.17) - 0.02 (0.11) -1.77 (1.27) 0.07 (0.11)
Attended genetic counseling -3.09 (2.24) 0.01 (0.22) -5.37* (2.45) 0.01 (0.22)
Cancer history 0.57 (1.52) -0.27* (0.15) - 0.02 (1.66) -0.34* (0.15)
Has a daughter — — — —
Parent carrier -0.09 (1.97) -0.11 (0.14) -1.55 (2.16) -0.13 (0.14)
Sister carrier 0.43 (1.89) -0.04 (0.12) 3.47* (2.08) 0.07 (0.12)
No caregiving 2.40* (1.43) -0.05 (0.14) 2.43 (1.57) -0.13 (0.14)
Some caregiving 0.76 (1.36) -0.05 (0.14) -1.19 (1.49) -0.19 (0.14)
A great deal of caregiving 3.37* (1.65) - 0.02 (0.18) 3.72* (1.81) -0.29* (0.17)
Carrier x suspect -0.74 (2.50) 0.10 (0.24) -1.65 (2.77) 0.29 (0.24)
SAS -0.14* (0.07) - 0.0 1 * (0.01) -0.24 (0.07) - 0.01 (0.01)
F-STRAIN -0.31* (0.08) 0.00 (0.01) -0.24* (0.08) 0.01 (0.01)
F-COPES 0.18* (0.04) - 0.0 1 * (0.00) 0.17* (0.05) - 0.0 1 * (0.00)
*p < 0,10, 
tP < 0,05, 
*P < 0,01,
family functioning along both cohesion and adaptability 
dimensions. A more salient difference, however, is that 
changes in family functioning only seem to be affected by 
men's caregiving responsibilities/roles and that the changes 
are only significant and negative along the adaptability 
dimension (—0.29).
Discussion
This study expands previous research conducted by Mclner- 
ney-Leo et al. (11) who reported no significant changes in 
family cohesion, expressiveness, and conflict up to 6 to 9
months after BRCA1/2 genetic testing. However, their meas­
ures and analytic approach varied markedly from this study. 
In contrast to this study, which uses the Family Adaptability 
and Cohesion Evaluation Scales, Mclnerney-Leo et al. (11) 
used the Family Relationship Index, a subscale of the Family 
Environment Scale. We also accounted for additional factors 
that were likely to confound the effects of genetic testing such 
as individual anxiety levels, family coping resources, existing 
family strains, and the carrier status of other family members. 
Finally, we analyzed data from more points in time (baseline, 4 
months, and 1 year) using a different analytic approach 
(hierarchical linear modeling).
Table 4. Significant factors associated w ith initial (baseline) family cohesion and adaptability and subsequent changes 
(slope) 1 yr after BRCA1 genetic risk notification: women
Final estimation of fixed effects Cohesion Adaptability
Intercept coefficient (SE) Slope coefficient (SE) Intercept coefficient (SE) Slope coefficient (SE)
Carrier -1.13 (1.20) -0.09 (0.13) -1.53 (1.37) -0.13 (0.14)
Don't know carrier status -0.85 (2.29) 0.17 (0.24) -1.85 (2.63) 0.32 (0.25)
Age (continuous) -0.02 (0.05) 0.01 (0.01) 0.03 (0.06) 0.00 (0.01)
No children living in home 1.99 (1.41) 0.17 (0.15) 0.99 (1.62) 0.28* (0.16)
Household education -0.16 (0.23) 0.03 (0.02) 0.13 (0.27) 0.02 (0.03)
Household income -0.05* (0.02) 0.00 (0.00) -0.06* (0.03) 0.00 (0.00)
Married to single -8.75* (3.05) 0.25 (0.32) -2.86 (3.51) 0.29 (0.33)
Stayed single -6.01 (2.38) 0.05 (0.25) -1.67 (2.74) - 0.21 (0.26)
Suspect higher risk -2.26* (1.09) 0.03 (0.11) -3.21 * (1.25) 0.10 (0.12)
Attended genetic counseling -3.29* (1.41) 0.12 (0.15) -4.79* (1.62) 0.18 (0.16)
Cancer history 0.26 (1.11) -0.07 (0.11) 0.27 (1.28) - 0.02 (0.12)
Has a daughter -3.30* (1.77) -0.07 (0.18) -2.63 (2.04) -0.05 (0.19)
Parent carrier -2.59* (1.59) 0.06 (0.13) -2.72 (1.89) 0.07 (0.14) 
0.24* (0.12)Sister carrier 1.07 (2.36) 0.20* (0.11) 4.58* (2.81)
No caregiving 2.62* (1.46) -0.08 (0.15) 3.08* (1.68) -0.08 (0.16)
Some caregiving 1.51 (1.39) -0.21 (0.14) 1.70 (1.60) -0.10 (0.15)
A great deal of caregiving 1.45 (1.22) -0.02 (0.13) 3.09* (1.41) -0.03 (0.14)
Carrier x suspect -0.30 (2.69) 0.44 (0.27) 0.04 (3.10) 0.43 (0.29)
SAS -0.13* (0.06) 0.00 (0.01) -0.14* (0.07) 0.00 (0.01)
F-STRAIN -0.18* (0.08) 0.01 (0.01) -0.23* (0.09) 0.01 (0.01)
F-COPES 0.15 (0.04) - 0.00 (0.00) 0.21* (0.04) - 0.00 (0.00)
*p < 0,10, 
t P < 0,05, 
*P < 0,01,
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Gender of the tested individual moderated the effect of 
genetic test results as women did not report significant 
changes in overall family functioning after being notified of 
their genetic status. Male carriers, on the other hand, reported 
increasing familial adaptability. It is possible that men who 
leam that they are carriers are faced with this novel challenge 
that they had not previously considered as seriously as women 
had. Given this new status, men's increased levels of 
adaptability may reflect a need or willingness for greater 
flexibility within the family to accommodate their new position 
and health threat. Whereas the same could be said for female 
carriers, these women are likely to have contemplated being a 
carrier in light of the extensive female cancer history in the 
sample families. Accordingly, changes in adaptability may 
have already happened well before receiving genetic test 
results. We did not find significant effects of carrier status on 
family cohesion, a result that is consistent with those of 
Mclnemey-Leo et al. (11).
We also found that for men, unlike women, state anxiety 
levels had a significant negative effect on family cohesion 
regardless of carrier status. This suggests that men may be 
more vulnerable to the stress associated with the BRCA1 
genetic testing process than women, holding constant other 
factors. It is possible that other psychological states not 
assessed and used in this study (i.e., depressive symptoms, 
trait anxiety) might account for the remaining variance among 
men as regards cohesion declines over time. In particular, trait 
anxiety may capture a more persistent mood state, which may 
be a better predictor of family functioning in a long-term study 
such as this. The fact that there was no relationship between 
anxiety levels and change in cohesion among women might be 
further evidence that BRCA1 genetic testing may not be a 
significant stressor event for women who are already at higher 
risk for breast and ovarian cancer (23).
Selection bias may also be playing a role in the effect of 
anxiety on perceived family functioning. Because all of the 
men in this sample have living daughters, they may have self­
selected themselves into the project. Their anxiety may be 
linked to the heritability and risk factors associated with 
BRCA1 mutations that predispose their daughters to develop­
ing breast and ovarian cancer. As such, these men may then 
choose to participate in this study, thereby affecting the 
relationship between anxiety level and family functioning.
The effect of family coping strategies also plays a significant 
role for both men and women in terms of perceived changes in 
family adaptability and cohesion. However, contrary to 
previous research, higher amounts of coping do not necessar­
ily lead to better adjustment to stressful life events (24) or 
genetic testing (25). Among the men in this sample, higher 
amounts of family coping strategies before genetic testing 
decrease the degree to which families are able to adapt and 
interact after the genetic testing experience. More detailed 
analysis showed that families of male probands undergoing 
genetic testing, who cope by reframing or redefining stressful 
life events to make them more manageable, may suffer 
declines in family cohesiveness, and coping by seeking 
spiritual support may be detrimental to family adaptability. 
Why these attributes of coping are detrimental to families with 
a parent undergoing BRCA1 genetic testing remains unan­
swered, and additional qualitative or ethnographic informa­
tion will be needed to examine the process by which reframing 
has its effects. However, the psychosocial stress perspective 
and the Resiliency Model underscore the notion that the types 
and amount of coping strategies before genetic testing do not 
necessarily mean they are adequate or appropriate after 
genetic results are disclosed.
This study also found that other life circumstances alter the 
family's adjustment after genetic testing. Although the results 
are less consistent between men and women and between 
cohesion and adaptability, we found that having a history of
cancer, having a carrier sister, and being a caregiver for a first- 
degree female relative with cancer affect the family's adjust­
ment after BRCA1 genetic testing. Men with a history of cancer 
were shown to report greater rates of declining family 
adaptability and cohesion up to 1 year after genetic testing. 
Perhaps the genetic testing experience may have stimulated 
repressed negative feelings and experiences associated with 
previous cancer diagnosis and treatment. More research 
examining men's psychological response is needed to more 
fully understand the effects of BRCA1 genetic testing.
We showed that, among women, having a carrier sister 
increases adaptability and cohesion. It is important to note that 
the increases in family adaptability and cohesion refer to the 
female proband's nuclear family and not family functioning 
between the proband and her siblings or parent. We did not 
consider the timing in which family members were tested and 
received their genetic test results because it was not always 
possible to know how results were communicated among 
family members. It was therefore not possible to know whether 
families in this study were affected by knowledge of their 
sisters' carrier status (increasing cohesiveness and adaptabil­
ity). We also cannot rule out the possibility that preexisting 
levels of cohesiveness of the family facilitated communication 
of genetic test results, which in turn influenced other female 
members of the kindred to participate in this study.
Unlike women, men with a great deal of caregiving 
involvement for a female relative with cancer reported 
significantly greater rates of decline in adaptability relative to 
men who did not have affected relatives. The lack of significant 
effects on adaptability for women may arise because more 
women in this sample report being involved a great deal in the 
care of a relative with cancer and have already adapted 
accordingly. In contrast, men may be experiencing greater 
difficulty negotiating the effects of genetic testing on top of the 
financial, time, and, possibly, behavioral demands imposed by 
the caregiver role.
There are three noteworthy caveats to our findings. 
According to the Resiliency Model, how one appraises the 
potential effect of an event (i.e., perceiving an event as a 
potential source of stress) is a key element in the negotiation of 
life events. However, appraisal was not measured and, 
therefore, not accounted for in the analysis. A study of 
cancer-specific distress among women at high risk of breast 
and ovarian cancer (23) showed that women reported greater 
distress with the possibility of receiving a positive test result 
(BRCA1/2 mutation carrier) than being tested or receiving a 
negative test result (BRCAl/2 noncarrier). Future studies on 
family functioning and genetic testing should account for the 
family's appraisal of genetic risk notification. Second, the 
sample is predominantly Mormon and from Northern Euro­
pean descent; thus, generalizing the findings of this study may 
be limited to these populations. Finally, communication 
among family members as regards their genetic results may 
have biased our measure of "prior suspicions of cancer risk" 
because members who tested positive may have discussed 
their results with other members who had not completed the 
baseline interview.
The discovery of BRCA1 gene mutations has broadened 
the practice of genetic testing into a more preventive context, 
allowing tested individuals to prepare for and, possibly, 
attenuate the effects of breast and ovarian cancer. This 
study expands previous research by examining longitudinal 
changes in family relationships as a result of genetic testing. 
Although results show that tested parents are perceiving 
a decline in family functioning after genetic risk notification, 
there is no evidence to suggest that the decline is due to 
carrier status. In fact, it is other life circumstances that exist at 
the time of the genetic testing process that seem to influence 
the degree to which families adjust to the experience and test 
results.
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The implications for genetic testing policies are clear. 
When individuals and families are interested in genetic testing, 
the informed consent process must be as comprehensive as 
possible. This process includes disclosure of the potential 
familial effects of the testing experience overall as well as the 
specific genetic result. Typically, the psychosocial intake 
involves gathering information about an individual's coping 
resources and strategies. Our research suggests that it would 
be valuable to expand that intake to include information about 
the life stresses (caregiving, work, and other anxieties) and the 
coping resources and strategies associated with the nuclear 
family as well. This will alert counselors to the possibility that 
individuals or families may be preoccupied with other more 
immediate concerns and events. If the counselor finds an 
excess of stress on the family, that individuals seeking testing 
have high levels of general anxiety, or that the family does not 
have adequate amounts and sources of support, this may have 
an effect on long-term familial adjustment after genetic testing. 
Therefore, the consent process should include either additional 
strategies for coping or a dialogue about the readiness of the 
individual to have blood drawn.
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